刘毅铭
个人概况
刘毅铭律师是科律律师事务所上海办事处主管合伙人。刘律师经常代表生命科学与医疗健康以及高科技行业的公司客户,为他们提供涉及公司生命周期各发展阶段的法律咨询服务。他擅长代表高成长型公司、机构投资者和投资银行进行各类战略交易且拥有丰富的经验,包括香港和美国首次公开发行、跨境并购、私募融资、合资企业以及许可和合作协议等。
经验
-
Phrontline Announces Global Strategic Partnership With Samsung Bioepis
-
ImmuneOnco Biopharmaceuticals Announces HK$350.9 Million Placement of New Shares
-
Argo Biopharma Announces Multi-Asset License and Option Agreements With Novartis
-
Akeso Announces HK$3.97 Billion Placement of Shares
-
Innogen Pharmaceutical Announces HK$682.87 Million IPO
荣誉与排名
汤森路透《亚洲法律杂志》(Asian Legal Business)
“亚洲交易律师”
(2024年)
《商法》“The A-List法律精英”
外资律所“律界精锐”
(2023-2025年)
《法律500强》亚太榜单(The Legal 500 Asia Pacific)
“中国生命科学与医疗健康业务(国际律所):领先合伙人”
(2025年)
《钱伯斯大中华区法律指南》
“中国生命科学业务(国际律所):新锐律师”
(2025年)
《国际金融法律评论》(IFLR1000) 亚太榜单
“中国资本市场、并购、私募股权业务(国际律所):卓越律师”
(2024年)
汤森路透《亚洲法律杂志》(Asian Legal Business)
“2022 ALB China十五佳资本市场律师”
(2022年)
汤森路透《亚洲法律杂志》(Asian Legal Business)
“2022 ALB China十五佳律师新星”
(2022年)
Get In Touch
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.